BCRX - BioCryst Pharmaceuticals Stock Trading

BioCryst Pharmaceuticals Inc.(NASDAQ: BCRX) stock trading, description, contact, officers and directors.

About BioCryst Pharmaceuticals Inc.

Not available

Stock Information

BioCryst Pharmaceuticals Inc. Company Name:

BCRX Stock Symbol:

NASDAQ Market:

BCRX - BioCryst Pharmaceuticals Stock Trading

Get BCRX Alerts

News, Short Squeeze, Breakout and More Instantly...

BCRX - BioCryst to Present at 20th Annual Needham Virtual Healthcare Conference

RESEARCH TRIANGLE PARK, N.C., April 07, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company will present at the 20 th Annual Needham Virtual Healthcare Conference on Wednesday, April 14, 2021 at 8:45 a.m. ET. Links to a live a...
BCRX - BioCryst's Oral Factor D Inhibitor, BCX9930, Advancing to Pivotal Trials in PNH Following Successful Proof of Concept Trial

—Following doses of 400 mg bid or 500 mg bid of oral BCX9930, 100 percent of treatment-naïve patients and 83 percent of C5 inadequate response patients were transfusion-free— —Mean hemoglobin increased from 8.3 g/dL to 11.8 g/dL in treatment-na&#x...
BCRX - BioCryst Appoints Helen Thackray, M.D., as Chief Research and Development Officer

RESEARCH TRIANGLE PARK, N.C., March 19, 2021 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq:BCRX) today announced that the company has appointed Helen Thackray, M.D., FAAP, to the newly created position of chief research and development officer. In this role, Dr. Thack...